Viatris Inc. (VTRS) Deep Dive Video

Summary

Viatris exits the divestiture hangover and re-rates as a de-levered, cash-rich “total return” pharma—if 2026 specialty approvals and China execution hold.

View VTRS stock page · Read the VTRS research report

Loading the video player…